This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Affymax Announces Upcoming Webcasts And Conference Participation

Affymax, Inc. (Nasdaq: AFFY) today announced the company's participation in the following investor conferences next week.

--

 

Baird 2012 Health Care Conference

Wednesday, September 5, 2012
10:10 a.m. Eastern Time (7:10 a.m. Pacific Time)

--

Stifel Nicolaus 2012 Healthcare Conference

Thursday, September 6, 2012
8:00 a.m. Eastern Time (5:00 a.m. Pacific Time)
 

A live webcast of the presentations will be available on the investors section of the Company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentations.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.

The company's first marketed product, OMONTYS ® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,072.07 +48.01 0.27%
S&P 500 2,115.24 +6.95 0.33%
NASDAQ 5,023.8330 +18.4420 0.37%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs